Skip to main content
TipRanks
Go Ultimate75% OFF

Cardiol Therapeutics (CRDL) Income Statement

236 Followers

Cardiol Therapeutics Income Statement

Last quarter (Q3 2026), Cardiol Therapeutics's total revenue was C$0.00. In Q3, Cardiol Therapeutics's net income was C$-13.32M. See Cardiol Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementMar 26Mar 25Mar 24Dec 22Dec 21
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 78.76K
C$ 0.00C$ -373.11KC$ -248.35KC$ -219.91KC$ 78.76K
C$ 34.32MC$ 39.90MC$ 29.54MC$ 41.34MC$ 38.74M
Depreciation and AmortizationC$ 101.98KC$ 373.11KC$ 248.35KC$ 219.91KC$ 220.42K
C$ -34.21MC$ -36.30MC$ -27.88MC$ -30.71MC$ -38.44M
C$ -34.32MC$ -40.28MC$ -29.79MC$ -50.34MC$ -45.47M
C$ 497.42KC$ 3.60MC$ 1.66MC$ 10.41MC$ 7.03M
C$ -33.82MC$ -36.68MC$ -28.13MC$ -30.93MC$ -31.64M
C$ -33.82MC$ -36.68MC$ -28.13MC$ -11.52MC$ -24.72M
Per Share Metrics
Basic EPSC$ -0.39C$ -0.51C$ -0.44C$ -0.18C$ -0.57
Diluted EPSC$ -0.39C$ -0.51C$ -0.44C$ -0.18C$ -0.57
Weighted Average Shares Outstanding86.99M71.57M64.46M62.51M43.22M
Weighted Average Shares Outstanding (Diluted)86.99M71.57M64.46M62.51M43.22M

Currency in CAD

Cardiol Therapeutics Earnings and Revenue History

-40M-20M020M-31393 %-31392 %-31391 %-31390 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin